Log-in
Sign-up
Webcast
Clinical Trials
Webcast
Clinical Trials
Home
>
Clinical Trials
Molecules
전체
Edoxaban
Olmesartan
Prasugrel
Pravastatin
Mirogabalin
Ramosetron
Trastuzumab deruxtecan
Status
Select
Check All
Search
Recruiting
Completed
Not yet recruiting
Enrolling by invitation
Active, not recruiting
Suspended
Terminated
Withdrawn
Unknown status
Email
Saved trials
Unknown status
NCT02604797
Analgesia Effects of Nalbuphine vs Sulfentanil
80
Enrollment(s)
0
Study location(s)
Interventional (Not Applicable)
C.Delivery; Surgery (Previous), Gynecological
Completed
NCT01615198
Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Elderly Patients With Essential Hypertension
588
Enrollment(s)
78
Study location(s)
Interventional (Phase III)
Essential Hypertension
Completed
NCT01599104
Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Japanese Patients With Essential Hypertension
1,161
Enrollment(s)
61
Study location(s)
Interventional (Phase III)
Essential Hypertension
Completed
NCT00918411
A Preliminary Study to Explore Clinical Endpoints in Patients (Male) With Diarrhea-predominant Irritable Bowel Syndrome
98
Enrollment(s)
0
Study location(s)
Interventional (Phase IV)
Irritable Bowel Syndrome
Unknown status
NCT02561884
A Single-dose, Randomized, Two-period, Two-treatment, Two-sequence, Crossover Bioequivalence Study on a Olostar Tab Versus Two Co-administered Reference Products Olmesartan Medoxomil and Rosuvastatin Calcium in Healthy Volunteers
58
Enrollment(s)
0
Study location(s)
Interventional (Phase I)
Healthy
Completed
NCT01752374
Palonestron, Granisetron and Ramosetron for Prevention of Postoperative Nasea and Voming After Laparoscopic Abdominal Surgery
90
Enrollment(s)
1
Study location(s)
Observational
Female Patients Undergoing Laparoscopic Abdominal Surgery
Completed
NCT00997503
TAXUS Libert? Post Approval Study
4,199
Enrollment(s)
82
Study location(s)
Observational
Coronary Artery Disease
Unknown status
NCT02516826
The Effect of Rosuvastatin and Olmesartan on the Progression of Coronary Atherosclerotic Disease
504
Enrollment(s)
1
Study location(s)
Interventional (Phase II)
Coronary Syndrome
76
77
78
79
80